Mpox in Africa is no longer a global health emergency, WHO chief says
Source: SeekingAlpha
2025-09-06 11:04:59 ET
More on Bavarian Nordic, Abbott, etc.
- Bavarian Nordic A/S 2025 Q2 - Results - Earnings Call Presentation
- Bavarian Nordic A/S (BVNKF) Q2 2025 Earnings Call Transcript
- Tonix Pharmaceuticals Soars, Then Sinks: What's Next After Tonmya's Approval (Upgrade)
- Medtronic wins FDA nod to integrate Abbott’s Instinct sensor with MiniMed 780G
- Emergent Biosolutions awarded $30 million contract modification for CYFENDUS
Read the full article on Seeking Alpha
For further details see:
Mpox in Africa is no longer a global health emergency, WHO chief says
Emergent Biosolutions Inc.
NASDAQ: EBS
EBS Trading
-0.06% G/L:
$8.065 Last:
212,002 Volume:
$8.23 Open:
EBS Latest News
March 03, 2026 08:00:00 am
Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors
February 26, 2026 04:05:00 pm
Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results
February 26, 2026 04:01:00 pm
Emergent BioSolutions Announces Approximately $140 Million in Contract Awards with the Government of Canada, Strengthening Canada's Leadership in Health Preparedness
February 26, 2026 04:01:00 pm
Emergent BioSolutions Announces New $50 Million Stock Repurchase Program
EBS Stock Data
$592,950,394
50,839,325
1.42%
58
N/A
Pharmaceuticals
Healthcare
US
Gaithersburg
